Search Browse Earnings

Regencell Bioscience Holdings Ltd — SlamSEC

Regencell Bioscience Holdings Ltd

Nasdaq:RGC

Medicinal Chemicals & Botanical Products·HONG KONG

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$6.0M

FY 2025

Net Income

-$5.9M

FY 2025

EPS (Diluted)

-$1.19

FY 2025

Stock Price

$23.66

-3.4%

2026-03-11

52W Range

$0.10 – $83.60

P/E Ratio

-19.9x

Market Cap

$11.7B

Cash

$59,413

FY 2022

Total Debt

$3.0M

FY 2023

Net Debt

$2.9M

FY 2023

Enterprise Value

$11.7B

Debt / EBITDA

-0.5x

FY 2025

EV / EBITDA

-1956.8x

Employees

—